Oct 31, 2022 09:01AM
Oct 31, 2022 09:00AM
Aug 31, 2022 05:41AM
Aug 30, 2022 11:21PM
Aug 17, 2022 09:00AM
Aug 16, 2022 09:00AM
Jul 7, 2022 09:30AM Sorrento's (SRNE) Scilex to Acquire Ancora Medical
Jul 7, 2022 09:30AM
Jul 5, 2022 02:04PM
Jun 14, 2022 10:37AM
Jun 14, 2022 10:33AM
Jun 3, 2022 09:02AM
Jun 3, 2022 09:00AM
May 18, 2022 09:30AM Sorrento's (SRNE) Scilex to Initiate Phase 2 Study of SP-103
May 18, 2022 09:30AM
May 16, 2022 09:04AM
May 16, 2022 09:00AM
May 11, 2022 09:01AM
May 11, 2022 09:00AM
May 5, 2022 08:05PM
Apr 27, 2022 09:00AM Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., to Present SP-102 (SEMDEXA™) Efficacy and Safety Data from its Pivotal Phase 3 Clinical Trial Program for Sciatica
Apr 25, 2022 12:48PM
Apr 25, 2022 12:46PM
Apr 25, 2022 09:00AM
Apr 13, 2022 05:40AM
Apr 12, 2022 09:15PM
Apr 11, 2022 09:50AM
Apr 11, 2022 09:48AM VICKERS VANTAGE CORP. I EXTENDS TIME TO COMPLETE BUSINESS COMBINATION
Apr 4, 2022 09:03AM
Apr 4, 2022 09:00AM
Mar 25, 2022 09:03AM
Mar 25, 2022 09:00AM
Mar 23, 2022 12:07PM
Mar 18, 2022 09:02AM
Mar 18, 2022 09:00AM Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., Announces Final Results for SP-102 (SEMDEXA™) Efficacy and Safety from its Pivotal Phase 3 Clinical Trial Program
Mar 17, 2022 03:36PM
Mar 17, 2022 03:35PM
Jan 7, 2022 10:34AM
Jan 7, 2022 10:30AM
Dec 9, 2021 09:00AM
Dec 6, 2021 09:02AM
Dec 6, 2021 09:00AM Scilex Holding Company, a Sorrento Therapeutics Inc. Subsidiary, and Vickers Vantage Corp I (NASDAQ: VCKA) (“SPAC”) Enter into Letter of Intent for Proposed Business Combination
Jun 1, 2021 04:00PM
Jun 1, 2021 04:00PM
Jan 7, 2021 06:04AM

1,185,523 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All